Latest Neurology (clinical) research
The 10 most useful neurology (clinical) studies published this week, chosen from Q1 journals and graded on the Oxford CEBM evidence hierarchy. Each paper links to a short summary and the original on PubMed. Updated 7 November 2026.
Top 10 this week
Week of 1 November 2026
- 1
Effects of minocycline on health-related quality of life in patients with acute ischaemic stroke in China: a prespecified secondary analysis of the EMPHASIS trial
EClinicalMedicine · Q1 journal · RCT · Evidence level 1 (High) · 22 September 2026
In a prespecified analysis of 1,697 trial participants in China, 73.4% of patients given minocycline reached a favorable health state at 90 days, compared with 68.9% given placebo. The main quality-of-life score did not differ significantly between groups in the primary analysis, and the visual rating was also similar; the modest gains need confirmation.
- 2
Effect of Sequential Electroacupuncture Combined With Augmented Reality Gait Training on Walking Function and Neuromuscular Control in Subacute Stroke: A Randomized Controlled Trial
American journal of physical medicine & rehabilitation · Q1 journal · RCT · Evidence level 1 (High) · 14 September 2026
Electroacupuncture plus AR gait training improves stroke walking
- 3
Comparative Safety and Efficacy of Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized-Controlled Clinical Trials
Stroke · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 29 October 2026
In a network analysis of six trials involving 18,395 patients with atrial fibrillation and prior stroke or transient ischemic attack, apixaban was the only drug to significantly reduce both stroke and major bleeding versus warfarin. Other blood thinners also reduced some bleeding outcomes, but comparisons between drugs were indirect, so the analysis cannot establish which is best.
- 4
Epidural Spinal Cord Stimulation for Spasticity: A Systematic Review
Neuromodulation : journal of the International Neuromodulation Society · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 25 September 2026
A review of nine prospective studies found an average 1.77-point reduction in spasticity scores among adults treated with epidural spinal cord stimulation; 62% to 80% improved, and some also gained function. Reported adverse events were under 10%, but the studies included just 176 treated patients and varied widely, so larger standardized trials are needed to clarify who benefits.
- 5
Effects of exercise-based interventions on balance and functional mobility in adults with chronic stroke: a systematic review and meta-analysis
Frontiers in public health · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 13 October 2026
Across 69 randomized trials involving 2,314 adults with chronic stroke, exercise-based programs improved balance and reach, and reduced the time to complete a mobility test by an average of 2.7 seconds. Evidence certainty ranged from moderate to high, but results varied across measures; larger trials are needed to identify the best training dose and whether benefits last.
- 6
Trial of Endovascular Therapy for Mild Stroke with Large-Vessel Occlusion
The New England journal of medicine · Q1 journal · RCT · Evidence level 1 (High) · 23 October 2026
Randomized trial evaluates thrombectomy for mild stroke with occlusion
- 7
Safety and Efficacy of Anodal transcranial direct-current stimulation over the Dorsolateral Prefrontal Cortex in Post-Stroke Cognitive Impairment: A Systematic Review and Meta-Analysis
Complementary therapies in medicine · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 29 October 2026
Across 23 trials involving 1,326 people, anodal transcranial direct-current stimulation over the prefrontal cortex improved Montreal Cognitive Assessment scores by about 3 points and also improved daily functioning. The results were similar across control groups and stimulation sites, but low study quality and sparse safety reporting leave the size and risks of the benefit uncertain.
- 8
Pharmacological Interventions for Neurological Manifestations of Ataxia-Telangiectasia: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials
Cerebellum (London, England) · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 31 October 2026
Across six randomized trials of drugs for ataxia-telangiectasia, two levacetylleucine trials showed no significant pooled improvement on an ataxia rating scale, with results varying substantially. A separate pooled analysis found better scores with erythrocyte-encapsulated dexamethasone, but neither trial met its primary neurological endpoint. The findings leave treatment effects uncertain and highlight the need for better outcome measures.
- 9
Left Atrial Appendage Occlusion versus Oral Anticoagulation in Atrial Fibrillation: A Meta-Analysis of Randomized Trials
JACC. Advances · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 1 October 2026
In six randomized trials involving 7,004 people with atrial fibrillation, left atrial appendage closure reduced nonprocedural major bleeding by 29% - one fewer event for every 19 patients treated - and also reduced clinically relevant nonmajor bleeding. Ischemic strokes were more frequent, but that finding was fragile; overall stroke and mortality were similar, leaving the benefit-harm tradeoff central to treatment decisions.
- 10
Internet Intervention for Functional Seizures: A Randomized Clinical Trial
JAMA neurology · Q1 journal · RCT · Evidence level 1 (High) · 26 October 2026
In a randomized trial analysis of 96 adults, a self-guided online program plus standard care reduced monthly functional seizure frequency by 65% compared with standard care alone, with the difference sustained through 12 months. Anxiety also improved, but therapist guidance did not significantly reduce seizures; the single-clinic study leaves its reach beyond specialist care uncertain.
Paper of the day, last two weeks
Efficacy of cognitive behavioral therapy for anxiety and depression symptoms in Parkinson's disease patients: a systematic review and meta-analysis
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 5 November 2026
Across 21 randomized trials involving 892 people with Parkinson's disease, cognitive behavioral therapy was linked to moderate reductions in anxiety and depression symptoms. Effects were larger in programs lasting more than 10 weeks, but results varied substantially between studies; standardized trials and longer follow-up are needed to clarify how durable the benefits are.
Long-Term Efficacy of Adjunctive Cenobamate by Focal Seizure Subtypes: Open-Label Extension of a Randomized Clinical Study in a Multinational Asian Population
Neurology and therapy · Q1 journal · RCT · Evidence level 1 (High) · 3 November 2026
In an open-label extension involving 357 Asian adults with difficult-to-control focal seizures, median seizure frequency fell 83% to 100% across three seizure subtypes during maintenance treatment; about three-quarters had at least half as many seizures. Most patients entering the extension completed 52 weeks, but without a control group, the results cannot establish how much of the reduction was due to cenobamate.
Net Clinical Benefit of Continuing vs Discontinuing Anticoagulation After Atrial Fibrillation Ablation: Results from a 280,000-Patient Meta-Analysis
Thrombosis and haemostasis · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 2 November 2026
In a meta-analysis of 280,415 patients, continued anticoagulation after ablation was linked to nearly three times the odds of major bleeding and more than three times the odds of brain bleeding, with no clear reduction in ischemic stroke. The overall balance favored stopping, but randomized trials showed no difference and the findings may not apply to patients at highest stroke risk.
Comparative Effects of Neurostimulation- and Technology-Augmented Robot-Assisted Training on Upper-Limb Motor Recovery After Stroke: A Systematic Review and Network Meta-Analysis
Archives of physical medicine and rehabilitation · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 3 November 2026
In a review of 103 trials, robot-assisted training combined with repetitive magnetic brain stimulation was associated with a 9.6-point higher arm-function score than usual care; low-frequency electrical stimulation plus training was associated with a 7.5-point gain. The magnetic-stimulation combination ranked highest, but varied results, limited direct comparisons and low-to-moderate evidence certainty leave the best approach unsettled.
Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) in adults with chronic stroke: a randomized controlled trial
Annals of physical and rehabilitation medicine · Q1 journal · RCT · Evidence level 1 (High) · 31 October 2026
In a randomized trial of 46 adults with chronic stroke, a two-week, 50-hour therapy program improved bimanual hand use compared with usual rehabilitation, with gains still seen three months later. Participants also improved on several measures of arm function and daily activities, but the trial found no significant between-group benefit on lower-limb measures.
Maternal and Fetal Safety Outcomes of Thrombolytics for Ischemic Stroke in Pregnancy: A Systematic Review and Aggregated Case Series
Neurology · Q1 journal · SR of cohorts · Evidence level 2 (Moderate) · 30 October 2026
In 216 published cases of thrombolysis during pregnancy, including 85 for stroke, miscarriage risk was 12.4% higher than in the general pregnant population, and stillbirth risk was 5.9% higher. Symptomatic brain bleeding in mothers was similar to rates in young patients treated outside pregnancy, but the case-based evidence cannot reliably separate treatment effects from risks of the underlying illness.
Relationship Between the eTICI Score Before Randomization and 90-Day Outcome: A Post Hoc Analysis of ANGEL-TNK Trial
Stroke · Q1 journal · RCT · Evidence level 5 (Expert Opinion) · 29 October 2026
Randomized-trial analysis informs post-thrombectomy thrombolysis
FXIa inhibitors and secondary stroke prevention
Current opinion in neurology · Q1 journal · Non-randomized trial · Evidence level 2 (Moderate) · 27 October 2026
In the phase 3 OCEANIC-STROKE trial, adding asundexian to single or dual antiplatelet therapy reduced recurrent ischemic stroke by 26% in people with noncardioembolic stroke, without increasing major bleeding or bleeding in the brain. The result supports FXIa inhibition as a new prevention strategy, but further trials must confirm the benefit and clarify how long to treat.
Functional Benefit and Safety of Adjunctive Intra-Arterial Thrombolysis After Successful Endovascular Thrombectomy: An Updated and Cumulative Meta-Analysis of Randomized Trials
Journal of clinical medicine · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 9 October 2026
Randomized-trial meta-analysis evaluates adjunctive thrombolysis after thrombectomy
Mechanical Thrombectomy 24 to 72 Hours after Large-Vessel Ischemic Stroke
The New England journal of medicine · Q1 journal · RCT · Evidence level 5 (Expert Opinion) · 23 October 2026
Randomized trial of thrombectomy 24–72 hours after stroke
Intra-Arterial Alteplase After Successful Endovascular Reperfusion in Patients Without Intravenous Thrombolysis: A Subgroup Analysis of the PEARL Randomized Clinical Trial
Journal of the American Heart Association · Q1 journal · RCT · Evidence level 1 (High) · 23 October 2026
In this prespecified analysis of 189 patients, 43% given intra-arterial alteplase after successful thrombectomy had excellent function at 90 days, compared with 23% receiving standard care. Symptomatic brain bleeding and mortality did not differ significantly, but this subgroup result does not settle safety or show whether the benefit applies beyond patients who did not receive IV thrombolysis.
Remote Versus In-Person Follow-up Programming After Subthalamic Deep Brain Stimulation for Parkinson's Disease: A Multicenter Randomized Noninferiority Trial
Movement disorders : official journal of the Movement Disorder Society · Q1 journal · RCT · Evidence level 1 (High) · 23 October 2026
In a 52-person trial, remote follow-up programming after initial in-person setup met the prespecified noninferiority margin for motor outcomes at 90 days compared with in-person follow-up. Other clinical and patient-reported outcomes were broadly comparable, with similar serious adverse event rates. The small trial supports short-term use, but longer-term safety and effectiveness remain unknown.
Evidence summaries in Neurology (clinical)
Get this list every morning
The Web of Medicine app builds this feed for your specialty daily, with filters by evidence level and journal, audio summaries and Ask AI. Free on iOS and Android.
For healthcare professionals. Summaries are generated by AI from the published abstract and are not medical advice. Read the original paper before changing practice.